This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Gambro Lundia Ab. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Giacomo Grandi: Innovator in Extracorporeal Blood Treatment
Introduction
Giacomo Grandi is a notable inventor based in Modena, Italy. He has made significant contributions to the field of medical technology, particularly in the area of blood treatment. With a total of 2 patents, his work focuses on improving the efficiency and safety of extracorporeal blood circulation.
Latest Patents
Giacomo's latest patents include innovations such as a disposable extracorporeal blood circuit and an apparatus for the extracorporeal treatment of blood. These inventions feature a rigid tubular piece and a cassette assembly designed for extracorporeal blood circulation. The rigid tubular piece is utilized for submitting fluid circulating within it to measurements. It includes a protrusion or a recess at least at one end connector. Additionally, the blood treatment medical apparatus using the cassette assembly is capable of detecting whether the rigid tubular piece is correctly positioned before allowing measurements of a blood property.
Career Highlights
Giacomo Grandi is currently associated with Gambro Lundia AB, a company known for its advancements in medical technology. His work at Gambro has allowed him to focus on developing innovative solutions for blood treatment, enhancing patient care and safety.
Collaborations
Giacomo has collaborated with notable colleagues such as Francesco Fontanazzi and Luca Caleffi. These partnerships have contributed to the development of his patents and the advancement of medical technology.
Conclusion
Giacomo Grandi's contributions to the field of extracorporeal blood treatment highlight his innovative spirit and dedication to improving medical technology. His patents reflect a commitment to enhancing patient safety and treatment efficiency.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
